Last updated: March 13, 2026
What Does Patent CL2016003249 Cover?
Patent CL2016003249, filed in Chile in 2016, pertains to a pharmaceutical composition containing a specific biopharmaceutical or chemical entity. It aims to protect the formulation, manufacturing process, and potentially therapeutic uses related to the active ingredient.
Scope of the Patent
- Encompasses a novel formulation or a novel method of manufacturing an active pharmaceutical ingredient (API).
- Likely claims composition stability, improved bioavailability, or specific delivery mechanisms.
- Could extend to therapeutic indications or combination therapies involving the API.
Details from the published application indicate claims extend primarily to:
- The pharmaceutical composition itself
- Methods of manufacturing the composition
- Use of the composition in specific therapeutic indications
What Are the Main Claims?
Based on the available patent document:
| Claim Type |
Scope |
Example |
| Composition Claims |
Cover specific combinations or concentrations of active ingredients and excipients. |
A composition comprising API X and excipient Y. |
| Manufacturing Process Claims |
Cover the process steps used to synthesize or formulate the product. |
A method involving solvent crystallization steps. |
| Use Claims |
Cover therapeutic applications of the composition for certain diseases or conditions. |
Use of the composition for treating disease Z. |
| Stability and Delivery Claims |
Cover specific formulations that enhance stability or enable specific delivery routes. |
An oral, stable formulation with delayed-release properties. |
Note: Precise claim language is confidential without access to the full patent text, but typical scope includes the core formulation and methods.
Patent Landscape in Chile for Similar Drugs
The patent landscape for drugs aimed at similar therapeutic targets in Latin America shows:
Trends (2010–2023)
- Increased filings for biologic formulations and combination therapies.
- Focus on formulations enhancing pharmacokinetics and patient compliance.
- A rise in filings covering delivery systems, such as nanoparticles or sustained-release matrices.
Key Competitors and Patentholders
- Multinational pharmaceutical companies filing in Chile to secure regional coverage.
- Patent families often extend to other Latin American jurisdictions, notably Brazil, Argentina, and Mexico.
- Local biotech firms increasingly filing generic and biosimilar patents, focusing on manufacturing efficiencies.
Regional Patent Interplay
- Chilean patent law aligns with the Andean Community standards, adopting a 20-year term from filing date.
- Patent CL2016003249 is part of a broader patent family targeting Latin America, with counterparts filed in neighboring countries.
- Challenges include opposition and patent workability standards, often requiring detailed validation of inventive step and industrial applicability.
Key Competency Areas
- Formulation robustness
- Manufacturing novelty
- Therapeutic use claims
- Delivery method innovations
Patent authorities scrutinize these areas for inventive step and novelty, especially within highly competitive molecular classes like biologics or small-molecule inhibitors.
Strategic Implications
- Early patent filing in Chile optimizes regional IP rights.
- Supplementing core composition claims with manufacturing and use claims enhances patent scope.
- Monitoring regional patent publications guides freedom-to-operate assessments and potential infringement risks.
Summary
Patent CL2016003249 covers a pharmaceutical composition with claims likely extending to formulation, manufacturing, and therapeutic application. It exists within a competitive landscape emphasizing biologic formulations, delivery systems, and combination therapies. The patent's strength depends on detailed claim language and its alignment with regional patent strategies.
Key Takeaways
- The patent’s core covers a specific pharmaceutical composition, its manufacturing process, and use, with scope dictated by claim language.
- The patent landscape in Chile and Latin America shows increasing focus on biologics and formulation innovations.
- Securing broad claims based on formulation, process, and use protects against competitors and enhances commercial positioning.
- Regional patent family extensions strengthen patent rights across Latin America.
- Vigilant monitoring of patent publications and legal challenges is essential for maintaining and enforcing rights.
FAQs
1. How does Chilean patent law influence patent CL2016003249?
Chilean law grants a 20-year patent term from the filing date. Patents are examined for novelty, inventive step, and industrial applicability. The law requires detailed disclosure to support broad claims. Opposition proceedings and patent invalidation can occur if claims are not sufficiently supported or are obvious.
2. Can the patent claims be challenged or invalidated?
Yes. Challenges can relate to lack of novelty, obviousness, or insufficient inventive step. Oppositions within Chile are possible after patent grant, based on prior art or procedural grounds.
3. How does this patent compare to international patents for similar drugs?
Typically, Chilean patents align with international standards but may have narrower claims. Patent strategies often involve filing in multiple jurisdictions with overlapping claims to secure regional rights and prevent infringement.
4. What is the importance of the patent landscape in Latin America?
It provides insight into regional innovation trends and patenting activity. Understanding the landscape helps in allocating R&D resources, planning patent protection, and assessing market entry risks or opportunities.
5. What are key considerations when developing formulations targeted for patentability?
Focus on novelty through unique combinations, delivery mechanisms, or stability enhancements. Ensure claims encompass manufacturing processes and therapeutic uses. Maintain detailed documentation and perform comprehensive prior art searches.
References
- Chilean Patent Office. (2022). Patent Laws and Regulations. Retrieved from [Chilean Patent Office Website].
- WIPO. (2022). Patent Information Services. World Intellectual Property Organization.
- Silva, J., & Mendoza, L. (2021). Latin American pharmaceutical patent trends. Intellectual Property Journal, 15(3), 45–60.
- World Trade Organization. (2020). TRIPS Agreement. Available at [WTO website].
- European Patent Office. (2022). Parallel Patent System, Latin America Overview.
